237 related articles for article (PubMed ID: 38099957)
1. Molecular features for timely cancer diagnosis and treatment - tumors of the ovary, fallopian tube and endometrium.
Gatius S; Matias Guiu X; Davidson B
Virchows Arch; 2024 Feb; 484(2):339-351. PubMed ID: 38099957
[TBL] [Abstract][Full Text] [Related]
2. Inherited mutations in fallopian tube, ovarian and primary peritoneal carcinoma: Changes in diagnoses and mutational frequency over 20 years.
Weiss AS; Swisher E; Pennington KP; Radke M; Khasnavis N; Garcia RL; Kilgore MR; Lee MK; Norquist BM
Gynecol Oncol; 2020 Oct; 159(1):214-220. PubMed ID: 32709535
[TBL] [Abstract][Full Text] [Related]
3. Processing of fallopian tube, ovary, and endometrial surgical pathology specimens: A survey of U.S. laboratory practices.
Samimi G; Trabert B; Duggan MA; Robinson JL; Coa KI; Waibel E; Garcia E; Minasian LM; Sherman ME
Gynecol Oncol; 2018 Mar; 148(3):515-520. PubMed ID: 29395311
[TBL] [Abstract][Full Text] [Related]
4. A retrospective study of Pipelle endometrial biopsy for ovarian, fallopian tube, and peritoneal cancers.
Tamura R; Kitani Y; Takahashi K; Yamaguchi M; Nishikawa N; Kawasaki T; Kikuchi A
J Obstet Gynaecol; 2023 Dec; 43(2):2283162. PubMed ID: 37983014
[TBL] [Abstract][Full Text] [Related]
5. The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.
Kurman RJ; Shih IeM
Am J Surg Pathol; 2010 Mar; 34(3):433-43. PubMed ID: 20154587
[TBL] [Abstract][Full Text] [Related]
6. [Significance and expression of PAX8, PAX2, p53 and RAS in ovary and fallopian tubes to origin of ovarian high grade serous carcinoma].
Mao YN; Zeng LX; Li YH; Liu YZ; Wu JY; Li L; Wang Q
Zhonghua Fu Chan Ke Za Zhi; 2017 Oct; 52(10):687-696. PubMed ID: 29060967
[No Abstract] [Full Text] [Related]
7. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
[TBL] [Abstract][Full Text] [Related]
8. Cancer of the ovary, fallopian tube, and peritoneum: 2021 update.
Berek JS; Renz M; Kehoe S; Kumar L; Friedlander M
Int J Gynaecol Obstet; 2021 Oct; 155 Suppl 1(Suppl 1):61-85. PubMed ID: 34669199
[TBL] [Abstract][Full Text] [Related]
9. Guideline No. 403: Initial Investigation and Management of Adnexal Masses.
Salvador S; Scott S; Glanc P; Eiriksson L; Jang JH; Sebastianelli A; Dean E
J Obstet Gynaecol Can; 2020 Aug; 42(8):1021-1029.e3. PubMed ID: 32736853
[TBL] [Abstract][Full Text] [Related]
10. Fallopian tube initiation of high grade serous ovarian cancer and ovarian metastasis: Mechanisms and therapeutic implications.
Bergsten TM; Burdette JE; Dean M
Cancer Lett; 2020 Apr; 476():152-160. PubMed ID: 32067992
[TBL] [Abstract][Full Text] [Related]
11. [The Fallopian tube odyssey: from the ovary to the tube. About high-grade serous ovarian carcinoma].
Chêne G; Dauplat J; Radosevic-Robin N; Cayre A; Penault-Llorca F
Bull Cancer; 2013; 100(7-8):757-64. PubMed ID: 23831931
[TBL] [Abstract][Full Text] [Related]
12. The 2020 Japan Society of Gynecologic Oncology guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer.
Tokunaga H; Mikami M; Nagase S; Kobayashi Y; Tabata T; Kaneuchi M; Satoh T; Hirashima Y; Matsumura N; Yokoyama Y; Kawana K; Kyo S; Aoki D; Katabuchi H
J Gynecol Oncol; 2021 Mar; 32(2):e49. PubMed ID: 33650343
[TBL] [Abstract][Full Text] [Related]
13. Cytomorphologic and molecular analyses of fallopian tube fimbrial brushings for diagnosis of serous tubal intraepithelial carcinoma.
Chui MH; Vang R; Wang TL; Shih IM; VandenBussche CJ
Cancer Cytopathol; 2019 Mar; 127(3):192-201. PubMed ID: 30861338
[TBL] [Abstract][Full Text] [Related]
14. Are all pelvic (nonuterine) serous carcinomas of tubal origin?
Przybycin CG; Kurman RJ; Ronnett BM; Shih IeM; Vang R
Am J Surg Pathol; 2010 Oct; 34(10):1407-16. PubMed ID: 20861711
[TBL] [Abstract][Full Text] [Related]
15. Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.
Crum CP; Drapkin R; Kindelberger D; Medeiros F; Miron A; Lee Y
Clin Med Res; 2007 Mar; 5(1):35-44. PubMed ID: 17456833
[TBL] [Abstract][Full Text] [Related]
16. The Fallopian Tube Origin and Primary Site Assignment in Extrauterine High-grade Serous Carcinoma: Findings of a Survey of Pathologists and Clinicians.
McCluggage WG; Hirschowitz L; Gilks CB; Wilkinson N; Singh N
Int J Gynecol Pathol; 2017 May; 36(3):230-239. PubMed ID: 27801755
[TBL] [Abstract][Full Text] [Related]
17. Mucosal Proliferations in Completely Examined Fallopian Tubes Accompanying Ovarian Low-grade Serous Tumors: Neoplastic Precursor Lesions or Normal Variants of Benign Mucosa?
Wolsky RJ; Price MA; Zaloudek CJ; Rabban JT
Int J Gynecol Pathol; 2018 May; 37(3):262-274. PubMed ID: 28700429
[TBL] [Abstract][Full Text] [Related]
18. Pathology of Ovarian Cancer: Recent Insights Unveiling Opportunities in Prevention.
Kommoss F; Gilks CB
Clin Obstet Gynecol; 2017 Dec; 60(4):686-696. PubMed ID: 28990983
[TBL] [Abstract][Full Text] [Related]
19. A case of fallopian tube carcinoma: successful preoperative diagnosis with MR imaging.
Kurachi H; Maeda T; Murakami T; Tsuda K; Narumi Y; Nakamura H; Miyake A; Murata Y
Radiat Med; 1999; 17(1):63-6. PubMed ID: 10378654
[TBL] [Abstract][Full Text] [Related]
20. Serous papillary cystadenofibroma of the fallopian tube: A case report and short review of literature.
Khatib Y; Patel RD; Kashikar AS; Chavan K
Indian J Pathol Microbiol; 2015; 58(4):524-7. PubMed ID: 26549083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
